Trial | NCT02242071  Report issue

Title

Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis
The Effect of Autologous Bone Marrow Mononuclear Cell Transplantation on Motor Neuron Disease/Amyotrophic Lateral Sclerosis

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Withdrawn

  • Study Participants

    0
The effect of autologous bone marrow mononuclear cells on Motor Neuron Disease/Amyotrophic Lateral Sclerosis patients.
Study Started
Dec 31
2008
Primary Completion
Mar 31
2015
Study Completion
Sep 30
2016
Last Update
Oct 25
2018

Biological Stem Cell

intrathecal autologous bone marrow mononuclear cell transplantation

Stem Cell Experimental

bone marrow mononuclear cell transplantation

Criteria 

Inclusion Criteria:

Patients with the diagnosis of definite Motor Neuron Disease/amyotrophic lateral sclerosis.
Age 18-80 years

Exclusion Criteria:

HIV/HBV/HCV
Malignancies
Bleeding tendencies
Pneumonia
Renal failure
Severe liver dysfunction
Severe anemia [hb < 8]
Any bone marrow disorder
Space occupying lesion in brain
Pregnancy and lactation
Other acute medical conditions/infections such as respiratory infection and pyrexia
left ventricular ejection fraction < 25%
Patient on artificial ventilatory support
No Results Posted